Abstract |
Riboflavin is an essential micronutrient for normal cellular activity, and deficiency may result in disease, such as cancer. We performed a case-control study to explore the association of riboflavin levels with risk and prognosis of esophageal squamous cell carcinoma (ESCC). Plasma riboflavin levels, as measured by enzyme-linked immunosorbent assay (ELISA), in ESCC patients were significantly lower than in those of healthy controls (7.04 ± 6.34 ng/ml vs. 9.32 ± 12.40 ng/ml; P < 0.05). Moreover, there was an inverse relationship between riboflavin level and risk of ESCC (odds ratio (OR) = 0.97, 95% confidence interval (CI) = 0.95-0.99, P = 0.02). The 5-year relapse-free and overall survival rates were significantly lower when riboflavin levels were ≤0.8 ng/ml than >0.8 ng/ml (relapse-free survival rate: 29.4% vs. 54.8%; overall survival rate: 28.6% vs. 55.6%). Plasma riboflavin level was an independent protective factor for both relapse-free (hazard ratio (HR) = 0.325, 95% CI = 0.161-0.657, P = 0.002) and overall survival of ESCC patients (HR = 0.382, 95% CI = 0.190-0.768, P = 0.007). In conclusion, plasma riboflavin levels are significantly related to risk and prognosis of ESCC patients, suggesting that moderate supplementation of riboflavin will decrease risk and prevent recurrence of ESCC and also improve prognosis of ESCC patients.
|
Authors | Shan-Shan Li, Yi-Wei Xu, Jian-Yi Wu, Hua-Zhen Tan, Zhi-Yong Wu, Yu-Jie Xue, Jian-Jun Zhang, En-Min Li, Li-Yan Xu |
Journal | Nutrition and cancer
(Nutr Cancer)
Vol. 69
Issue 1
Pg. 21-28
(01 2017)
ISSN: 1532-7914 [Electronic] United States |
PMID | 27898225
(Publication Type: Journal Article)
|
Chemical References |
- Biomarkers, Tumor
- Membrane Transport Proteins
- SLC52A3 protein, human
- Riboflavin
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Biomarkers, Tumor
(blood)
- Carcinoma, Squamous Cell
(blood, mortality, pathology)
- Case-Control Studies
- Esophageal Neoplasms
(blood, mortality, pathology)
- Esophageal Squamous Cell Carcinoma
- Female
- Humans
- Kaplan-Meier Estimate
- Male
- Membrane Transport Proteins
(genetics)
- Middle Aged
- Polymorphism, Single Nucleotide
- Prognosis
- Riboflavin
(blood)
|